Search Results

FDA Approves Larger Implant Size of Intact Vascular’s Tack Endovascular System

January 28, 2020—Intact Vascular, Inc. announced FDA premarket approval for the expansion of the company’s Tack endovascular system 6-F portfolio.

HistoSonics Edison System to Treat Kidney Tumors Completes Pivotal Trial Enrollment

June 11, 2025—HistoSonics, Inc. recently announced the completion of patient enrollment in the #HOPE4KIDNEY pivotal trial of its Edison histotripsy system.

CE Mark Approved for Vivasure Medical's Fully Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures

January 8, 2016—Vivasure Medical announced European CE Mark approval of its fully bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies.

Medtronic's Symplicity Spyral Multielectrode Catheter and Symplicity G3 Generator Approved in Europe and Australia

December 5, 2013—Medtronic, Inc. (Minneapolis, MN) announced European CE Mark and Australian Therapeutic Goods Administration listing for the company's highly flexible, 4-F multielectrode Symplicity Spyral catheter and Symplicity G3 radiofrequency (RF) generator.

Lesion Preparation Using Diamondback 360 OAS Shown to Enhance Paclitaxel Distribution in Calcified PAD

September 11, 2017—CBSET announced that its scientists have published data and analyses regarding the barrier effects of calcified plaque on drug delivery and the treatment success of adjunctive lesion preparation therapy in the treatment of peripheral atherosclerosis.

Terumo Launches PriorityOne AC Aspiration Catheter

August 22, 2012—Terumo Interventional Systems (Somerset, NJ) announced the United States launch of the PriorityOne AC aspiration catheter for thrombus removal from the coronary or peripheral arteries.

Wallaby Medical Will Distribute Brainomix e-Stroke Software Platform in China

August 26, 2021—Wallaby Medical and Brainomix Limited announced the signing of a new distribution agreement.

Medtronic Highlights Efforts to Tackle Hypertension With Patient Preference Data Presentation and SPYRAL AFFIRM Study Commencement

November 9, 2021— Medtronic recently announced data from their Patient Preferences for the Treatment of Hypertension study that suggest patients may have a tolerance for some risk of adverse events, such as vascular injury or drug side effects, in exchange for being able to lower their office-based systolic blood pressure.

Expanse ICE’s Innovative Aspiration Thrombectomy System Cleared by FDA

April 22, 2024—Expanse ICE announced that its ICE aspiration system has received FDA 510(k) clearance for the peripheral thrombectomy market.

MedAlliance’s SELUTION4BTK IDE Trial Begins Enrollment

June 8, 2022—MedAlliance announced that the first patient has been enrolled in the SELUTION4BTK trial.

ACS and SVS Launch National Quality Verification Program for Vascular Care

March 23, 2023—The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), announced the launch of the Vascular Verification Program (Vascular-VP), a national quality verification program to help participating hospitals improve outcomes and deliver the best treatment for patients receiving vascular surgical and interventional care in an inpatient setting.

Cagent Vascular’s Serranator Device in BTK Arteries Compared to POBA in RECOIL Study

July 11, 2023—Cagent Vascular, a Pennsylvania-based developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its below-the-knee (BTK) Serranator RECOIL study.

Terumo’s Azur HydroPack Peripheral Coil System Launched in United States

December 11, 2023—Terumo Medical Corporation announced the United States launch of the Azur HydroPack peripheral coil system.

Thrombolex Names Michael Cerminaro as CEO, Succeeding Marvin Woodall

July 15, 2022—Thrombolex announced that its Board of Directors has named Michael Cerminaro as Chief Executive Officer (CEO) of the company effective July 13, 2022.

Salus Scientific Appoints Michael Lankford as Vice President of Sales

March 6, 2026—Salus Scientific Corporation, a developer of radiation protection garments and clinical workflow solutions for fluoroscopy-guided environments, announced the appointment of Michael Lankford as Vice President of Sales.